Genistein-based BIO 300 clinical trials
Also written BIO 300.
How each study uses Genistein-based BIO 300 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Genistein-based BIO 300 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2015 | 1 |
| 2020 | 2 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 1
Humanetics Corporation (5) · Memorial Sloan Kettering Cancer Center (1)
Related medicines
As reviewed, each with the page that says it.
- One of Antioxidants source
Studies
Open first, then newest update. How each study uses Genistein-based BIO 300 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung DiseaseRecruitingPhase 2Memorial Sloan Kettering Cancer CenterNCT07323732Written as BIO 300
- Phase 1 BIO 300 Oral SuspensionCompletedPhase 1Humanetics CorporationNCT06741345Written as BIO 300 Oral Suspension
- BIO 300 Oral Suspension in Previously Hospitalized Long COVID PatientsActive, not recruitingPhase 2Humanetics CorporationNCT04482595Written as BIO 300 Oral Suspension
- BIO 300 Oral Powder Safety and PharmacokineticsCompletedPhase 1Humanetics CorporationNCT04650555Written as BIO 300 Oral Powder
- BIO 300 Non-Small Cell Lung Cancer StudyCompletedPhase 1/2Humanetics CorporationNCT02567799Written as BIO 300 Oral Suspension
- Safety and Pharmacokinetic Study of BIO 300 CapsulesCompletedPhase 1Humanetics CorporationNCT00504335Written as BIO 300 Capsules